Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
April 25 2024
The effect of a Mediterranean diet on both gastrointestinal (GI) and psychological symptoms among people with irritable bowel syndrome (IBS) was recen...
Proton Pump Inhibitor (PPI) are widely used by millions of people for indications and durations that were never tested or approved, and are available via prescription or as over the counter (OTC) in several countries including the United States. They are often overprescribed, rarely deprescribed, and frequently started inappropriately during a hospital stay. Their use is often extended for log-term duration without appropriate medical indications. Studies estimate between 53% and 69% of PPI prescriptions are for inappropriate indications. While PPIs are generally perceived as a safe class of therapeutics, PPI use is associated with a number of adverse health outcomes. They include acute interstitial nephritis, chronic kidney disease and progression to end stage renal disease, a rare but potentially fatal risk of hypomagnesemia, increased risk of incident and recurrent Clostridium difficile infections, and even a higher risk of incident dementia. In this large primary cohort of new users of acid suppression therapy followed for a median of 5.71 years, researchers show a significant association between PPI use and risk of all-cause mortality. Risk was increased among those with no documented indication for PPI use and with prolonged duration of use.
Xie Y, Bowe B, Li T, et al. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans. BMJ Open 2017; e015735. Doi:10.1136/bmjopen-2016-015735
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment